Research Article
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
Table 1
Clinical and laboratory characteristics of ND and CT subjects.
| | Clinical characteristics | ND () | CT () | |
| | Age (years) | | | 0.320 | | Gender (males/females) | 36/28 | 36/28 | 1.0 | | Total cholesterol (mg/dl) | | | 0.122 | | Glycaemia (mg/dl) | | | 0.470 | | Systolic blood pressure (mmHg) | | | 0.579 | | Diastolic blood pressure (mmHg) | | | 0.720 | | BMI | | | 0.54 | | Hypertension | 46/24 | 48/16 | 0.843 | | Diabetes | 7/57 | 8/56 | 0.783 | | Dyslipidemia | 28/36 | 25/39 | 0.590 | | Current smoking | 2/61 | 3/61 | 0.648 | | Serum isoprostanes (pmol/l) | | | 0.005 | | sNOX2-dp (pg/ml) | | | <0.001 | | H2O2 (μM) | | | <0.001 | | LPS (pg/ml) | | | <0.001 | | LPS (EU/ml) | | | <0.001 | | Zonulin (ng/ml) | | | <0.001 | | ADL | | | <0.001 | | IADL | | | <0.001 |
|
|